08/16/2012

Microbix Biosystems Inc.

Microbix Returns to MEDICA


Microbix infectious disease antigens used in major diagnostic instruments world wide

Mississauga, Ontario, Aug. 15, 2012 – Microbix Biosystems Inc. (MBX:TSX), a Canadian biotechnology company and a major supplier of infectious disease antigens, will return to MEDICA, the world’s largest annual medical trade fair, taking place in Düsseldorf, Germany, Nov. 14-17.

“At MEDICA this year, we will be presenting new and enhanced options for developing infectious disease diagnostic tests” says Kevin Koole, Microbix general manager. “In addition, we will be discussing the growth areas of our product line, notably proficiency testing and molecular diagnostic control viruses as well as plans to offer new viral targets in 2012.”

Thanks largely to increased world-wide sales, Microbix recently reported strong financial results for its core biotech business. In the first half of the 2012 fiscal year, sales were up 31% compared to the same period in 2011, due primarily to growing customer demand for infectious disease antigens and viral and bacterial growth for pharmaceutical and vaccine development. The figures indicate that the market for well characterized viral antigens remains robust, especially for products providing reliable performance and superior clinical sensitivity.

For other biotech markets, Microbix is currently developing LumiSort ®, a next-generation instrument-based (cytometric) technology that creates sex-selected sperm cell preparations – or sperm sexing, for short. LumiSort will provide the artificial insemination industry with a 3-fold increase in sperm cell yield and a 10-fold increase in the speed of production, while increasing the fertility of the sexed sperm cell product.

Microbix recently expanded its sales force in Europe with a new office in Paris. The Company has also established a distribution centres in China to ease overseas shipping costs. New distribution channels, along with a continually expanding and improving product line have made Microbix viral antigens the choice of nine of the world’s 10 largest diagnostic manufacturers.

Microbix antigens include:
- Hepatitis A virus
- Rubella virus
- Chlamydia
- Dengue virus
- Adenovirus
- Parainfluenza virus
- Rotavirus
- Cytomegalovirus
- Herpes Simplex 1&2
- Measles virus
- Influenza virus
- Varicella-Zoster virus
- Respiratory Syncytial virus
- Epstein-Barr virus.

At MEDICA 2012, Microbix will be exhibiting in booth K53, Hall 3 as part of the Ontario, Canada pavilion and welcomes the media, visitors, and old friends.

For further information, please contact Kevin Koole kevin.koole@microbix.com
+1-905-361- 8910 x228

-30-